After a quick 20 minute review of results, I'm satisfied. Management continue to tick all the right boxes for me and the future looks prosperous. They've been pretty consistent in meeting their targets, and so I'm satisfied with "at least 25% increase in adjusted cash EBITDA".
I haven't had a good look yet at the nitty gritty progress of their pharmaceutical R & D and see no mention in their 4 page summary, and won't have a chance to review in detail until later tonight.
Interested to know everyone else's thoughts.
Overall Opinion on Results
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)